The safety agency's latest advisory said that patients with a "permanent" version of the abnormal heartbeat called atrial fibrillation shouldn't get the medicine, generically called dronedarone. ❋ Thomas M. Burton (2011)
The French pharmaceutical company developed Multaq, generically known as dronedarone, as a treatment of a heart condition called atrial fibrillation, or irregular heartbeat. ❋ Unknown (2008)
The drug, also known as dronedarone, carries a black-box warning that it shouldn’t be used in patients who have recently had severe heart failure, because it can cause severe problems including death. ❋ Unknown (2009)
"I am excited by the launch of dronedarone which is a valuable additional choice for the treatment of AF. ❋ Unknown (2010)
Food and Drug Administration said it was "alerting health-care professionals and patients about cases of rare, but severe liver injury, including two cases of acute liver failure leading to liver transplant in patients treated with the heart medication dronedarone Multaq." ❋ A H Mooradian (2011)
The FDA said that "since dronedarone's approval in July 2009 through October 2010, around 492,000 dronedarone prescriptions were dispensed and around 147,000 patients filled dronedarone prescriptions at outpatient retail pharmacies in the United States." ❋ A H Mooradian (2011)
Sanofi has forecast annual sales of more than €1 billion ($1.41 billion) for Multaq, generically known as dronedarone. ❋ Unknown (2009)
Sanofi still plans to resubmit the drug, dronedarone, for regulatory approval in the U.S. and Europe by the end of September because a more recent study suggested the drug reduced the risk of death in patients with a heart condition known as atrial fibrillation, or irregular heartbeat. ❋ Unknown (2008)
In the updated label, the Food and Drug Administration said Multaq, known chemically as dronedarone, should not be used by patients who have permanent atrial fibrillation AF, a type of abnormal heart rhythm. ❋ Unknown (2011)
I'll cite just one very recent and ongoing example: dronedarone Multaq, which is a case study of all that can go wrong when conflicts of interest run amok.
National Institute for Health and Clinical Excellence, or NICE, in England and Wales, published a new appraisal consultation document, or ACD, for Multaq, or dronedarone, indicating its intention to recommend Multaq use for the management of patients with atrial ❋ Unknown (2010)
Cedars-Sinai Heart Institute researchers review dronedarone In a rigorous new review of the antiarrhythmic depression Transcendental meditation, a stress-busting technique, may help reduce symptoms of depression, according to two new studies. ❋ Unknown (2010)
ACD, for Multaq, or dronedarone, indicating its intention to recommend Multaq use for the management of patients with atrial ❋ Unknown (2010)
In a rigorous new review of the antiarrhythmic drug dronedarone (Multaq), researchers at the Cedars-Sinai Heart Institute conclude that the controversial drug is only modestly effective and has no clear safety benefits. ❋ Unknown (2010)
Cedars-Sinai Heart Institute researchers review dronedarone In a rigorous new review of the antiarrhythmic drug dronedarone ❋ Unknown (2010)
New arrhythmia drug provides only modest efficacy and no clear safety benefits say researchers drug dronedarone (Multaq), researchers at the Cedars-Sinai Heart Institute conclude that the controversial drug is only modestly ❋ Unknown (2010)
